# § 520.1445   Milbemycin oxime and praziquantel.

(a) *Specifications.* Each chewable tablet contains:


(1) 2.3 milligrams (mg) milbemycin oxime and 22.8 mg praziquantel;


(2) 5.75 mg milbemycin oxime and 57 mg praziquantel;


(3) 11.5 mg milbemycin oxime and 114 mg praziquantel; or


(4) 23 mg milbemycin oxime and 228 mg praziquantel.


(b) *Sponsor.* See No. 058198 in § 510.600(c) of this chapter.


(c) *Conditions of use*—(1) *Dogs*—(i) *Amount.* Administer orally, once a month, a minimum dosage of 0.23 mg per pound (mg/lb) of body weight (0.5 mg per kilogram (mg/kg)) milbemycin oxime and 2.28 mg/lb of body weight (5 mg/kg) praziquantel.


(ii) *Indications for use.* For the prevention of heartworm disease caused by *Dirofilaria immitis* and for the treatment and control of adult roundworm (*Toxocara canis, Toxascaris leonina*), adult hookworm (*Ancylostoma caninum*), adult whipworm (*Trichuris vulpis*), and adult tapeworm (*Taenia pisiformis, Echinococcus multilocularis, E. granulosus,* and *Dipylidium caninum*) infections in dogs and puppies 2 pounds of body weight or greater and 6 weeks of age and older.


(iii) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.


(2) [Reserved]



---

[N] [77 FR 47512, Aug. 9, 2012, as amended at 82 FR 58556, Dec. 13, 2017]




